The effects of CRA 1000, a non-peptide antagonist of corticotropin-releasing factor receptor type 1, on adaptive behaviour in the rat

Neuropeptides

Volumn 35, Issue 2, 2001, Pages 100-109

  Harro, J ^a   Tonissaar M ^a   Eller, M ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 4 [4 (3 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 PYRIDINYL] 2 [N ETHYL N (4 ISOPROPYL 2 METHYLTHIOPHENYL)AMINO] 6 METHYLPYRIMIDINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ADAPTIVE BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FORCED SWIMMING TEST; LOCUS CERULEUS; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

ANIMALIA;

EID: 0034968078     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2001.0851     Document Type: Article

References (54)

1. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I Acutely presented stressful and nonstressful stimuli
2. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: Evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1
3. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat
4. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effect following infusion into the locus coeruleus
5. 1 receptor antagonists, CRA1000 and CRA 1001
6. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
7. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress
8. 1 receptor antagonists
9. Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin
10. Functional supersensitivity to adrenergic agonists after DSP-4, a selective noradrenergic neurotoxin
11. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems
12. Behavioral responses to stress are intact in CRF-deficient mice
13. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?
14. A CRF antagonist attenuates stress-induced increases in NA turnover in extended brain regions in rats
15. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154, 526 in anxiety models in rodents
16. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?
17. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
18. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour
19. Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics
20. B receptor binding in the rat brain after chronic antidepressant treatment
21. Impaired exploratory behaviour after DSP-4 treatment in rats: Implications for the increased anxiety after noradrenergic denervation
22. Depression as a spreading neuronal adjustment disorder
23. Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and β-adrenoceptor binding in the rat
24. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: A microdialysis study in vivo
25. Differential effects of two corticotropin-releasing factor antagonists on conditioned defeat in male Syrian hamsters (Mesocricetus auratus)
26. The behavioural effects of corticotropin-releasing factor-related peptides in rats
27. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat
28. Overflow of noradrenaline and dopamine in frontal cortex after [N(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: In vivo microdialysis study in anaesthetized rats
29. 1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test
30. 1 receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups
31. 1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats
32. 2 receptor antisense oligodeoxynucleotides into the rat brain differentially affects emotional and stress coping behavior
33. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
34. A non peptidic corticotropin releasing factor antagonist attenuates fever and exhibits anxiolytic-like activity
35. 1 receptor antagonist
36. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat
37. Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
38. Characterization of rat exploratory behaviour using the exploration box test
39. Physiology and pharmacology of corticotropin-releasing factor
40. Hippocampal norepinephrine-like voltammetric responses following infusion of corticotropin-releasing factor into the locus coeruleus
41. Behavioural despair in rats: A new model sensitive to antidepressant treatments
42. Characterization of native corticotropin-releasing factor receptor type A (CRFA) in the rat and mouse central nervous system
43. Injection of corticotropin-releasing hormone into the locus coeruleus or foot shock increases neuronal Fos expression
44. Long-term effect of N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart
45. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
46. CRF receptor antagonist attenuates stress-induced noradrenaline release in the medial prefrontal cortex of rats
47. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems
48. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex
49. CRF receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats
50. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
51. Corticotropin-releasing factor produces behavioral activation in rats
52. Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats
53. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor
54. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus